Our WES data demonstrated that genes within regions of recurrent deletions previously demonstrated to be important in SS pathogenesis (TP53 on chromosome 17, CDKN2A on chromosome 9 and PTEN on chromosome 10) also were affected by deleterious mutations. This evidence concerns the gene CDKN2A and synovial sarcoma.